Whereas the preceding studies demonstrate that 12-LOX inhibition with p.o. VLX-1005 delays the development of diabetes, they do not address whether administration of the drug might reverse established diabetes or mitigate hyperglycemia. Here, ALOX12 is linked to Hyperglycemia.